Sunflower Pharmaceuticals Group Co Ltd Financial Flexibility Index
Sunflower Pharmaceuticals Group Co Ltd financial flexibility index. Sunflower Pharmaceuticals Group Co Ltd (002737) has a Financial Flexibility Index of -0.08x as of September 2025. Free cash flow of CN¥-71.93 Million (operating CF CN¥-117.97 Million minus capex CN¥46.03 Million) represents 0% of total liabilities (CN¥891.55 Million). See Sunflower Pharmaceuticals Group Co Ltd (002737) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sunflower Pharmaceuticals Group Co Ltd (2011–2025)
Financial flexibility index of Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2025. Historical Financial Flexibility Index trend for Sunflower Pharmaceuticals Group Co Ltd across 15 annual periods. Check how high is Sunflower Pharmaceuticals Group Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Sunflower Pharmaceuticals Group Co Ltd Financial Flexibility Index by Year (2011–2025)
Sunflower Pharmaceuticals Group Co Ltd financial flexibility index by year from 2011 to 2025. Year-by-year free cash flow to debt coverage for Sunflower Pharmaceuticals Group Co Ltd. For the full cash flow conversion analysis, see Sunflower Pharmaceuticals Group Co Ltd cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | CN¥671.07 Million | CN¥574.97 Million | CN¥1.34 Billion | ▲ +388.8% |
| 2024 | -0.17x | CN¥-214.69 Million | CN¥-307.48 Million | CN¥1.24 Billion | ▼ -130.4% |
| 2023 | 0.57x | CN¥1.07 Billion | CN¥923.30 Million | CN¥1.88 Billion | ▼ -30.2% |
| 2022 | 0.82x | CN¥2.12 Billion | CN¥1.97 Billion | CN¥2.59 Billion | ▲ +41.6% |
| 2021 | 0.58x | CN¥983.54 Million | CN¥865.23 Million | CN¥1.70 Billion | ▼ -27.9% |
| 2020 | 0.80x | CN¥1.38 Billion | CN¥1.17 Billion | CN¥1.72 Billion | ▲ +11.3% |
| 2019 | 0.72x | CN¥1.36 Billion | CN¥981.33 Million | CN¥1.88 Billion | ▼ -1.4% |
| 2018 | 0.73x | CN¥1.19 Billion | CN¥866.21 Million | CN¥1.62 Billion | ▲ +33.8% |
| 2017 | 0.55x | CN¥715.65 Million | CN¥558.77 Million | CN¥1.31 Billion | ▲ +55.0% |
| 2016 | 0.35x | CN¥500.72 Million | CN¥341.23 Million | CN¥1.42 Billion | ▲ +34.3% |
| 2015 | 0.26x | CN¥303.16 Million | CN¥125.84 Million | CN¥1.15 Billion | ▼ -36.5% |
| 2014 | 0.41x | CN¥600.94 Million | CN¥403.23 Million | CN¥1.45 Billion | ▲ +4.2% |
| 2013 | 0.40x | CN¥487.78 Million | CN¥293.34 Million | CN¥1.23 Billion | ▲ +2.1% |
| 2012 | 0.39x | CN¥441.53 Million | CN¥327.31 Million | CN¥1.14 Billion | ▼ -13.7% |
| 2011 | 0.45x | CN¥456.70 Million | CN¥257.60 Million | CN¥1.01 Billion | — |